What is the Active Ingredient in GLP-1?

GLP-1 medications have transformed weight loss and diabetes management by harnessing the power of hormones your body already produces. Understanding the active ingredients in these treatments helps you make informed decisions about your health journey. PlexusDx provides access to both leading GLP-1 active ingredients in personalized formulations.

What Is GLP-1 and How Does It Function

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone your intestines release when you eat. This hormone acts as a chemical messenger that tells your brain you are satisfied, slows stomach emptying, and helps regulate blood glucose levels. Your body produces GLP-1 in response to nutrient intake, making it a key player in appetite control and metabolic health.

The discovery that GLP-1 affects both weight and blood sugar opened new doors for treating obesity and type 2 diabetes. Scientists recognized that boosting GLP-1 activity could help people eat less, feel fuller longer, and maintain steadier energy levels throughout the day. This biological insight led to the development of medications that mimic or enhance GLP-1 signaling in the body.

Active Ingredients in GLP-1 Medications

The two primary active ingredients in GLP-1 medications are semaglutide and tirzepatide, each with distinct chemical structures and mechanisms. Semaglutide is a GLP-1 receptor agonist that binds directly to GLP-1 receptors throughout your body, activating the same pathways as the natural hormone. In the STEP clinical trials, semaglutide demonstrated sustained weight loss and improvements in cardiovascular outcomes in adults with obesity.

Tirzepatide represents a newer class called GIP/GLP-1 receptor agonists, meaning it activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 pathways simultaneously. The SURMOUNT trials showed tirzepatide produced greater weight loss compared to semaglutide alone in head-to-head comparisons. PlexusDx offers compounded semaglutide injections starting at $179 monthly and tirzepatide injections from $229 monthly, with oral formulations also available.

PlexusDx also provides a Microdose GLP-1 Protocol at $129 monthly for individuals seeking a gentler starting approach, plus the GLP-Squared dual compound option ($249 monthly) that combines both active ingredients for enhanced results. All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality without the need for insurance or membership fees.

How GLP-1 Active Ingredients Work in Your Body

When you take a GLP-1 medication, the active ingredient enters your system and attaches to GLP-1 receptors on nerve cells in your brain, particularly in areas controlling hunger and satiety. This receptor activation sends signals that reduce appetite signals, increase feelings of fullness, and decrease cravings for food. The effect is not sedation or artificial hunger suppression—it is a biological reset of your appetite regulation system.

Beyond appetite control, GLP-1 active ingredients slow the rate at which your stomach empties food into your small intestine. This extended digestion means nutrients absorb more gradually, preventing rapid blood sugar spikes and crashes. Tirzepatide's dual action on GIP receptors adds another layer by enhancing insulin secretion in response to meals, further stabilizing glucose levels and reducing fat storage.

Weight Loss Benefits Driven by GLP-1 Active Ingredients

Clinical evidence consistently demonstrates that GLP-1 active ingredients produce meaningful weight reduction. In STEP trials, semaglutide users lost an average of 15–22% of body weight over 68 weeks, with some participants achieving losses exceeding 25%. The weight loss stems directly from reduced calorie intake due to lower appetite and increased satiety, not from stimulant effects or dehydration.

Tirzepatide's dual-pathway approach in SURMOUNT trials achieved average weight losses of 20–24%, with the highest-dose group reaching 24.2% reduction from baseline. PlexusDx genetic testing through the Precision Peptide test ($99 add-on or $298 standalone) identifies genetic predispositions in peptide pathways that predict individual response to these active ingredients, helping optimize medication selection. This personalized approach means your medication matches your genetic biology, not a generic protocol.

Blood Sugar Control and Metabolic Health With GLP-1

For individuals with type 2 diabetes or prediabetes, GLP-1 active ingredients address the root problem: impaired glucose regulation. Semaglutide lowers hemoglobin A1C (a 3-month average of blood sugar) by 1.5–2.0 percentage points in clinical studies, reducing diabetes complications like kidney disease, vision loss, and heart attack. The effect occurs because GLP-1 slows carbohydrate absorption and enhances insulin release only when blood glucose rises, avoiding dangerous low-blood-sugar episodes.

Tirzepatide's additional GIP signaling further improves insulin sensitivity and reduces hepatic glucose production, making it especially effective for individuals with poor metabolic control. PlexusDx ensures all active ingredients are sourced from licensed 503A compounding pharmacies and remain HSA/FSA eligible, removing financial barriers to access across all 50 states. Personalization through genetic testing reveals which active ingredient—semaglutide, tirzepatide, or a combination—aligns with your peptide genetic pathways for maximum efficacy.

Frequently Asked Questions About What is the Active Ingredient in GLP-1?

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.